Thinking of joining a study?

Register your interest

NCT05908240 | RECRUITING | Psoriasis


Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
Sponsor:

University of Pennsylvania

Brief Summary:

The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Condition or disease

Psoriasis

Psoriatic Arthritis

Psoriatic Conditions

Cardiovascular Diseases

Intervention/treatment

Care Coordinator Model

Phase

NA

Detailed Description:

Psoriasis patients have an increased risk of cardiovascular disease and mortality but are less likely to have traditional cardiovascular risk factors identified or adequately managed. Care coordinators have previously been demonstrated to improve outcomes in patients with chronic diseases (such as comorbid diabetes and depression) and are now routinely embedded in primary care practices in integrated health systems. The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Study Type : INTERVENTIONAL
Estimated Enrollment : 520 participants
Masking : NONE
Primary Purpose : OTHER
Official Title : Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis: Translating Guidelines of Care to Better Outcomes for Patients With Psoriatic Disease
Actual Study Start Date : 2023-06-15
Estimated Primary Completion Date : 2025-09
Estimated Study Completion Date : 2025-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 40 Years to 75 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Willing and able to provide informed consent
  • 2. Male or female aged 40-75
  • 3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis
Exclusion Criteria
  • 1. Currently taking a prescription lipid lowering medication
  • 2. Pregnant or planning pregnancy in the next 6 months
  • 3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Location Details

NCT05908240


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Arkansas

Johnson Dermatology

Fort Smith, arkansas, United States, 72916

RECRUITING

United States, Indiana

Dawes Fretzin Clinical Research

Columbus, Indiana, United States, 47201

RECRUITING

United States, Indiana

Dawes Fretzin Clinical Research

Indianapolis, Indiana, United States, 46250

RECRUITING

United States, Michigan

MiSkinCenter

Northville, Michigan, United States, 48167

RECRUITING

United States, New York

SUNY Downstate

Brooklyn, New York, United States, 11203

RECRUITING

United States, Pennsylvania

City Dermatology

Bensalem, Pennsylvania, United States, 19020

RECRUITING

United States, Pennsylvania

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

RECRUITING

United States, Utah

University of Utah

Salt Lake City, Utah, United States, 84112

RECRUITING

United States, Virginia

University of Virginia

Charlottesville, Virginia, United States, 22903

RECRUITING

United States, Washington

Bellevue Dermatology Clinic

Bellevue, Washington, United States, 98004

Loading...